QQ客服 官方微博 反馈留言

	Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
	Liu, Zhefeng; Wu, Lin; Cao, Jun; Yang, Zhe; Zhou, Chengzhi; Cao, Liming; Wu, Hao; Shen, Haibo; Jin, Meiling; Zhang, Yong
刊名	ONCOTARGETS AND THERAPY
	2018
卷号	11页码:7323-7331
关键词	ERBB2 lung cancer afatinib survival heterogeneity
DOI	10.2147/OTT.S173391
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4581056
专题	山东大学
作者单位	1.Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, 28 Fuxing Rd, Beijing 100853, Peoples R China. 2.Hun
推荐引用方式 GB/T 7714	Liu, Zhefeng,Wu, Lin,Cao, Jun,et al. Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients[J]. ONCOTARGETS AND THERAPY,2018,11:7323-7331.
APA	Liu, Zhefeng.,Wu, Lin.,Cao, Jun.,Yang, Zhe.,Zhou, Chengzhi.,...&Mao, Xin 更多.(2018).Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients.ONCOTARGETS AND THERAPY,11,7323-7331.
MLA	Liu, Zhefeng,et al."Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients".ONCOTARGETS AND THERAPY 11(2018):7323-7331.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。